drugset / Trial / NCT00353964
Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to evaluate the safety and effectiveness of three concentrations of rEV131, a new investigational anti-inflammatory agent, compared to placebo (an inactive substance) and an FDA approved anti-inflammatory agent in patients with ocular inflammation who have undergone cataract extraction with intra-ocular lens implantation.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prenisolone sodium phosphate | Unknown | 1 % | — |
| Subject | VOTUCALIS | Protein / enzyme biologic | 0.625 mg/ml | — |
| Subject | VOTUCALIS | Protein / enzyme biologic | 1.25 mg/ml | — |
| Subject | VOTUCALIS | Protein / enzyme biologic | 2.5 mg/ml | — |